Italian Guidelines for the Management of Sporadic Primary Hyperparathyroidism.

Hyperparathyroidism bisphosphonate cinacalcet parathyroidectomy pharmacoeconomy. sporadic surgery surveillance

Journal

Endocrine, metabolic & immune disorders drug targets
ISSN: 2212-3873
Titre abrégé: Endocr Metab Immune Disord Drug Targets
Pays: United Arab Emirates
ID NLM: 101269157

Informations de publication

Date de publication:
23 Dec 2023
Historique:
received: 19 07 2023
revised: 04 09 2023
accepted: 25 09 2023
medline: 22 4 2024
pubmed: 22 4 2024
entrez: 22 4 2024
Statut: aheadofprint

Résumé

This guideline (GL) is aimed at providing a clinical practice reference for the management of sporadic primary hyperparathyroidism (PHPT) in adults. PHPT management in pregnancy was not considered. This GL has been developed following the methods described in the Manual of the Italian National Guideline System. For each question, the panel appointed by Associazione Medici Endocrinology (AME) and Società Italiana dell'Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro (SIOMMMS) identified potentially relevant outcomes, which were then rated for their impact on therapeutic choices. Only outcomes classified as "critical" and "important" were considered in the systematic review of evidence. Those classified as "critical" were considered for the clinical practice recommendations. The present GL provides recommendations about the roles of pharmacological and surgical treatment for the clinical management of sporadic PHPT. Parathyroidectomy is recommended in comparison to surveillance or pharmacologic treatment in any adult (outside of pregnancy) or elderly subject diagnosed with sporadic PHPT who is symptomatic or meets any of the following criteria: • Serum calcium levels >1 mg/dL above the upper limit of normal range. • Urinary calcium levels >4 mg/kg/day. • Osteoporosis disclosed by DXA examination and/or any fragility fracture. • Renal function impairment (eGFR <60 mL/min). • Clinic or silent nephrolithiasis. • Age ≤50 years. Monitoring and treatment of any comorbidity or complication of PHPT at bone, kidney, or cardiovascular level are suggested for patients who do not meet the criteria for surgery or are not operated on for any reason. Sixteen indications for good clinical practice are provided in addition to the recommendations. The present GL is directed to endocrinologists and surgeons - working in hospitals, territorial services or private practice - and to general practitioners and patients. The recommendations should also consider the patient's preferences and the available resources and expertise.

Identifiants

pubmed: 38644730
pii: EMIDDT-EPUB-136695
doi: 10.2174/0118715303260423231122111705
doi:

Types de publication

Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

e141223224531

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Fabio Vescini (F)

Endocrinology Unit, Azienda Sanitaria-Universitaria Friuli Centrale, P.O. Santa Maria della Misericordia, Udine, Italy.

Giorgio Borretta (G)

Department of Endocrinology, Diabetes and Metabolism, Ospedale Santa Croce and Carle Hospital, Cuneo, Italy.

Iacopo Chiodini (I)

Endocrinology Department, ASST Grande Ospedale Metropolitano di Niguarda, Milan, Italy.
Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy.

Marco Boniardi (M)

General Oncologic and Mini-invasive Surgery Department, ASST Grande Ospedale Metropolitano di Niguarda, Milan, Italy.

Marina Carotti (M)

Department of Radiology, AOU delle Marche, Ancona, Università Politecnica delle Marche, Ancona, Italy.

Elena Castellano (E)

Department of Endocrinology, Diabetes and Metabolism, Ospedale Santa Croce and Carle Hospital, Cuneo, Italy.

Cristiana Cipriani (C)

Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.

Cristina Eller-Vainicher (C)

Endocrinology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Sandro Giannini (S)

Clinica Medica 1, Department of Medicine, University of Padova, Padova, Italy.

Maurizio Iacobone (M)

Endocrine Surgery Unit, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.

Antonio Stefano Salcuni (AS)

Endocrinology Unit, Azienda Sanitaria-Universitaria Friuli Centrale, P.O. Santa Maria della Misericordia, Udine, Italy.

Federica Saponaro (F)

Department of Surgical, Medical, and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.

Stefano Spiezia (S)

Department of Endocrine and Ultrasound-Guided Surgery, Ospedale del Mare, Naples, Italy.

Annibale Versari (A)

Nuclear Medicine Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Italy.

Guido Zavatta (G)

Division of Endocrinology and Diabetes Prevention and Care, IRCCS AOU di Bologna, Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy.

Zuzana Mitrova (Z)

Department of Epidemiology, Lazio Region Health Service, Rome, Italy.

Rosella Saulle (R)

Department of Epidemiology, Lazio Region Health Service, Rome, Italy.

Simona Vecchi (S)

Department of Epidemiology, Lazio Region Health Service, Rome, Italy.

Debora Antonini (D)

High School of Economy and Management of Health Systems, Catholic University of Sacred Heart, Rome, Italy.

Michele Basile (M)

High School of Economy and Management of Health Systems, Catholic University of Sacred Heart, Rome, Italy.

Alexia Giovanazzi (A)

Azienda Provinciale per i Servizi Sanitari della Provincia Autonoma di Trento, Trento, Italy.

Agostino Paoletta (A)

Department of Endocrinology, ULSS6 Euganea, Padova, Italy.

Enrico Papini (E)

Endocrinology, Ospedale Regina Apostolorum, Albano Laziale, Italy.

Agnese Persichetti (A)

Ministry of Interior - Department of Firefighters, Public Rescue and Civil Defense, Rome, Italy.

Irene Samperi (I)

Endocrinology, ASL Novara, Italy.

Alessandro Scoppola (A)

Endocrinology, Ospedale Santo Spirito, Rome, Italy.

Roberto Novizio (R)

Endocrinology and Metabolism, Agostino Gemelli University Polyclinic (IRCCS), Catholic University of the Sacred Heart, Rome, Italy.

Pietro Giorgio Calò (PG)

SIUEC President, Department of Surgical Sciences, University of Cagliari, Cagliari, Italy.

Filomena Cetani (F)

Endocrine Unit 2, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Luisella Cianferotti (L)

Bone Metabolic Diseases Unit, Department of Experimental, Clinical and Biomedical Sciences, University of Florence, AOU Careggi, Florence, Italy.

Sabrina Corbetta (S)

Bone Metabolism and Diabetes, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.

Maria Luisa De Rimini (ML)

AIMN President, Nuclear Medicine Unit, AORN Ospedali dei Colli, Naples, Italy.

Alberto Falchetti (A)

Laboratory of Experimental Clinical Research on Bone Metabolism, Istituto Auxologico Italiano IRCCS, Milan, Italy.

Giovanni Iannetti (G)

SIUMB President, Ultrasound Unit, S. Spirito Hospital, Pescara, Italy.

Stefano Laureti (S)

General Practitioner, USL Umbria 1, Perugia, Italy.

Celestino Pio Lombardi (CP)

Endocrine Surgery, Ospedale Gemelli, Rome, Italy.

Bruno Madeo (B)

Unit of Endocrinology, Department of Medical Specialties, Ospedale Civile di Baggiovara, Azienda Ospedaliero-Universitaria di Modena, Italy.

Claudio Marcocci (C)

Endocrine Unit 2, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Sandro Mazzaferro (S)

Nephrology Unit at Policlinico Umberto I Hospital and Department of Translation and Precision Medicine, Sapienza University of Rome, Italy.

Vittorio Miele (V)

Department of Emergency Radiology, Careggi University Hospital, Florence, Baggiovara, Italy.

Salvatore Minisola (S)

UOC Medicina Interna A, Malattie Metaboliche dell'Osso, Ambulatorio Osteoporosi e Osteopatie Fragilizzanti, Sapienza University of Rome, Rome Italy.

Andrea Palermo (A)

Unit of Thyroid and Bone-Metabolic Diseases, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.

Jessica Pepe (J)

Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.

Alfredo Scillitani (A)

Unit of Endocrinology, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy.

Laura Tonzar (L)

Endocrinology Unit, Azienda Sanitaria-Universitaria Friuli Centrale, P.O. Santa Maria della Misericordia, Udine, Italy.

Franco Grimaldi (F)

AME past President, Udine, Italy.

Renato Cozzi (R)

AME President, Milan, Italy.

Roberto Attanasio (R)

AME Scientific Committee, Milan, Italy.

Classifications MeSH